---
figid: PMC5820294__fonc-08-00038-g001
figlink: /pmc/articles/PMC5820294/figure/F1/
number: F1
caption: Signaling pathways involved in the progression of extramammary Paget’s disease.
  (A) The aberrant activation of HER2, molecules involved in the RAS–RAF–MEK–ERK signaling
  or PI3K–AKT–mTOR signaling promote the proliferation and survival of Paget cells.
  Likewise, the androgen–androgen receptor (AR) signaling can induce the proliferation
  and survival of Paget cells. Red, Food and Drug Administration-approved drugs for
  other cancers that target aspects of this pathway. (B) The interaction of Paget
  cells with lymphatic endothelial cells (LECs) through the CXCR4–stromal cell-derived
  factor-1 (SDF-1) signaling or with CD163+Arg1+ M2 macrophages through the receptor
  activator of nuclear factor kappa-B ligand (RANKL)–RANK signaling facilitates metastasis
  of Paget cells.
pmcid: PMC5820294
papertitle: 'Metastatic Extramammary Paget’s Disease: Pathogenesis and Novel Therapeutic
  Approach.'
reftext: Keitaro Fukuda, et al. Front Oncol. 2018;8:38.
pmc_ranked_result_index: '2465'
pathway_score: 0.9311439
filename: fonc-08-00038-g001.jpg
figtitle: Signaling pathways involved in the progression of extramammary Paget’s disease
year: '2018'
organisms: Homo sapiens
ndex: d0df352f-df09-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5820294__fonc-08-00038-g001.html
  '@type': Dataset
  description: Signaling pathways involved in the progression of extramammary Paget’s
    disease. (A) The aberrant activation of HER2, molecules involved in the RAS–RAF–MEK–ERK
    signaling or PI3K–AKT–mTOR signaling promote the proliferation and survival of
    Paget cells. Likewise, the androgen–androgen receptor (AR) signaling can induce
    the proliferation and survival of Paget cells. Red, Food and Drug Administration-approved
    drugs for other cancers that target aspects of this pathway. (B) The interaction
    of Paget cells with lymphatic endothelial cells (LECs) through the CXCR4–stromal
    cell-derived factor-1 (SDF-1) signaling or with CD163+Arg1+ M2 macrophages through
    the receptor activator of nuclear factor kappa-B ligand (RANKL)–RANK signaling
    facilitates metastasis of Paget cells.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK3
  - AKT2
  - CCND3
  - CCND2
  - MAPK1
  - ERBB2
  - CCND1
  - CDK6
  - CDK4
  - CXCR4
  - MAPK14
  - MAP2K2
  - MAP2K1
  - AR
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3CA
  - PIK3R6
  - AKT3
  - AKT1
  - ARAF
  - MTOR
  - MAPK8
  - MAPK11
  - CD8A
  - CD8B
  - CXCL12
  - MAPK12
  - MAPK13
  - PIK3R4
  - RAF1
  - PIK3R5
  - EIF2AK3
  - CCL17
  - MAPK9
  - CDH2
  - BRAF
  - HRAS
  - CCR4
  - MAPK10
  - NRAS
  - PIK3CB
  - KRAS
  - TNFRSF11A
  - Testosterone
  - Vemurafenib
  - Dabrafenib
  - androgen
  - Trametinib
  - Cobimetinib
  - Everolimus
  - Temsirolimus
  - O
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND3
  entrez: '896'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND2
  entrez: '894'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: CDK4/6
  symbol: CDK6
  source: hgnc_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: CDK4/6
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: '''CXCR4'
  symbol: CXCR4
  source: hgnc_symbol
  hgnc_symbol: CXCR4
  entrez: '7852'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PIK3CA
  symbol: PIK3CA
  source: hgnc_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: CD8+
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8A
  entrez: '925'
- word: CD8+
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8B
  entrez: '926'
- word: SDF-1
  symbol: SDF1
  source: hgnc_prev_symbol
  hgnc_symbol: CXCL12
  entrez: '6387'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PERK
  symbol: PERK
  source: hgnc_alias_symbol
  hgnc_symbol: EIF2AK3
  entrez: '9451'
- word: CCL17
  symbol: CCL17
  source: hgnc_symbol
  hgnc_symbol: CCL17
  entrez: '6361'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: N-cadherin
  symbol: CDH2
  source: hgnc_symbol
  hgnc_symbol: CDH2
  entrez: '1000'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: CCR4
  symbol: CCR4
  source: hgnc_symbol
  hgnc_symbol: CCR4
  entrez: '1233'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RANK
  symbol: RANK
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF11A
  entrez: '8792'
chemicals:
- word: Testosterone
  source: MESH
  identifier: D013739
- word: Vemurafenib
  source: MESH
  identifier: C551177
- word: Dabrafenib
  source: MESH
  identifier: C561627
- word: androgen
  source: MESH
  identifier: D000728
- word: Trametinib
  source: MESH
  identifier: C560077
- word: Cobimetinib
  source: MESH
  identifier: C574276
- word: Everolimus
  source: MESH
  identifier: C107135
- word: Temsirolimus
  source: MESH
  identifier: C401859
- word: O
  source: MESH
  identifier: D013481
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC5820294__F1
redirect_from: /figures/PMC5820294__F1
figtype: Figure
---
